These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33525860)

  • 1. Management of inflammatory bowel disease in the COVID-19 era.
    Kim KO; Jang BI
    Intest Res; 2022 Jan; 20(1):3-10. PubMed ID: 33525860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.
    Kamath C; Brenner EJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100101. PubMed ID: 35496814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    Allez M; Fleshner P; Gearry R; Lakatos PL; Rubin DT
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S774-S779. PubMed ID: 32722757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned.
    Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study.
    Chiu NC; Chi H; Tai YL; Peng CC; Tseng CY; Chen CC; Tan BF; Lin CY
    J Med Internet Res; 2020 Aug; 22(8):e21257. PubMed ID: 32750008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of biologics in inflammatory bowel disease patients with COVID-19.
    Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
    Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children With Inflammatory Bowel Disease in the COVID-19 Main Endemic Focus: The Lombardy Experience.
    Sansotta N; Norsa L; Zuin G; Panceri R; Dilillo D; Pozzi E; Giacomo C; Moretti C; Celano R; Nuti F; Sgaramella P; Stefano MD; Salvatore S; Arrigo S; Motta V; D'Antiga L
    Front Pediatr; 2021; 9():607285. PubMed ID: 33968841
    [No Abstract]   [Full Text] [Related]  

  • 9. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
    Garcia KS; Moutinho BD; de Azevedo MFC; Queiroz NSF; Milani LR; Sanches LN; Barros LL; Oba J; Carlos AS; Damião AOMC; Sipahi AM
    Inflamm Intest Dis; 2020 Jun; 5(2):93-97. PubMed ID: 32984404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis.
    Alrashed F; Battat R; Abdullah I; Charabaty A; Shehab M
    BMJ Open Gastroenterol; 2021 Oct; 8(1):. PubMed ID: 34725056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic.
    Barnes A; Andrews J; Spizzo P; Mountifield R
    JGH Open; 2021 May; 5(5):585-589. PubMed ID: 34013059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
    Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL
    Can J Gastroenterol Hepatol; 2021; 2021():7591141. PubMed ID: 34858891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study.
    Chambers J; Malhi G; Mikail M; Khanna R; Wilson A
    J Can Assoc Gastroenterol; 2022 Dec; 5(6):251-255. PubMed ID: 36467597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    Siegel CA; Christensen B; Kornbluth A; Rosh JR; Kappelman MD; Ungaro RC; Johnson DF; Chapman S; Wohl DA; Mantzaris GJ
    J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S769-S773. PubMed ID: 33085972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The gastrointestinal effects of COVID–19 infection during childhood and among the children affected with inflammatory bowel disease].
    Tóbi L; Prehoda B; Balogh A; Dezsőfi-Gottl A; Cseh Á
    Orv Hetil; 2022 Feb; 163(6):214-221. PubMed ID: 35124570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study.
    Ashton JJ; Kammermeier J; Spray C; Russell RK; Hansen R; Howarth LJ; Torrente F; Deb P; Renji E; Muhammed R; Paul T; Kiparissi F; Epstein J; Lawson M; Hope B; Zamvar V; Narula P; Kadir A; Devadason D; Bhavsar H; Beattie RM
    Arch Dis Child; 2020 Dec; 105(12):1186-1191. PubMed ID: 32732316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.